GWENDOLYN TURLEY: Open Payments
NPI 1477276251 · WILLIAMSTOWN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,069 in 51 payments from 7 companies in 2025. Trend: 2023 $569 · 2024 $898 · 2025 $1,069
Food & beverage: $1,069
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $434 |
| Alkermes, Inc. | 17 | $190 |
| ABBVIE INC. | 13 | $188 |
| Otsuka America Pharmaceutical, Inc. | 4 | $159 |
| Axsome Therapeutics, Inc. | 3 | $70 |
| Supernus Pharmaceuticals, Inc. | 1 | $15 |
| Lundbeck LLC | 1 | $14 |
Products named: CAPLYTA, VRAYLAR, REXULTI, ARISTADA, Auvelity, LYBALVI, Qelbree.
Industry payments across KY — which companies pay providers there.
